Build Your Comparison

Side-by-side financial analysis
CLB logo
CLB
RES logo
RES
KO logo
KO
Try popular comparisons:

Stock Comparison

CLB vs RES vs KO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CLB
Core Laboratories N.V.

Oil & Gas Equipment & Services

EnergyNYSE • NL
Market Cap$586M
5Y Perf.-37.4%
RES
RPC, Inc.

Oil & Gas Equipment & Services

EnergyNYSE • US
Market Cap$1.53B
5Y Perf.+123.7%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$348.25B
5Y Perf.+81.1%

CLB vs RES vs KO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CLB logoCLB
RES logoRES
KO logoKO
IndustryOil & Gas Equipment & ServicesOil & Gas Equipment & ServicesBeverages - Non-Alcoholic
Market Cap$586M$1.53B$348.25B
Revenue (TTM)$525M$1.75B$49.28B
Net Income (TTM)$31M$21M$13.70B
Gross Margin17.8%11.4%61.7%
Operating Margin10.0%3.0%29.3%
Forward P/E21.2x35.5x24.7x
Total Debt$206M$95M$45.49B
Cash & Equiv.$23M$210M$10.27B

CLB vs RES vs KOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CLB
RES
KO
StockJun 20Jun 26Return
Core Laboratories N… (CLB)10062.6-37.4%
RPC, Inc. (RES)100223.7+123.7%
The Coca-Cola Compa… (KO)100181.1+81.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: CLB vs RES vs KO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: RES and KO are tied at the top with 3 categories each — the right choice depends on your priorities. The Coca-Cola Company is the stronger pick specifically for profitability and margin quality and dividend income and shareholder returns. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CLB
Core Laboratories N.V.
The Value Play

CLB is the clearest fit if your priority is value.

  • Lower P/E (21.2x vs 24.7x)
Best for: value
RES
RPC, Inc.
The Defensive Pick

RES has the current edge in this matchup, primarily because of its strength in sleep-well-at-night and defensive.

  • Lower volatility, beta 0.35, Low D/E 8.7%, current ratio 3.24x
  • Beta 0.35, yield 2.3%, current ratio 3.24x
  • 15.0% revenue growth vs CLB's 0.5%
Best for: sleep-well-at-night and defensive
KO
The Coca-Cola Company
The Income Pick

KO is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 56 yrs, beta -0.20, yield 2.5%
  • Rev growth 1.9%, EPS growth 23.6%, 3Y rev CAGR 3.7%
  • 118.2% 10Y total return vs RES's -45.9%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthRES logoRES15.0% revenue growth vs CLB's 0.5%
ValueCLB logoCLBLower P/E (21.2x vs 24.7x)
Quality / MarginsKO logoKO27.8% margin vs RES's 1.2%
Stability / SafetyRES logoRESBeta 0.35 vs CLB's 0.96, lower leverage
DividendsKO logoKO2.5% yield, 56-year raise streak, vs CLB's 0.3%
Momentum (1Y)RES logoRES+39.3% vs CLB's +5.3%
Efficiency (ROA)KO logoKO13.1% ROA vs RES's 1.4%, ROIC 15.8% vs 4.8%

CLB vs RES vs KO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CLBCore Laboratories N.V.
FY 2025
Service
75.9%$399M
Product
24.1%$127M
RESRPC, Inc.
FY 2025
Technical Services
94.4%$1.5B
Support Services
5.6%$91M
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B

CLB vs RES vs KO — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLKOLAGGINGRES

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 5 of 6 comparable metrics.

KO is the larger business by revenue, generating $49.3B annually — 93.9x CLB's $525M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to RES's 1.2%. On growth, RES holds the edge at +36.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCLB logoCLBCore Laboratories…RES logoRESRPC, Inc.KO logoKOThe Coca-Cola Com…
RevenueTrailing 12 months$525M$1.7B$49.3B
EBITDAEarnings before interest/tax$71M$221M$15.5B
Net IncomeAfter-tax profit$31M$21M$13.7B
Free Cash FlowCash after capex$24M$44M$12.6B
Gross MarginGross profit ÷ Revenue+17.8%+11.4%+61.7%
Operating MarginEBIT ÷ Revenue+10.0%+3.0%+29.3%
Net MarginNet income ÷ Revenue+5.9%+1.2%+27.8%
FCF MarginFCF ÷ Revenue+4.5%+2.5%+25.5%
Rev. Growth (YoY)Latest quarter vs prior year-1.4%+36.6%+12.1%
EPS Growth (YoY)Latest quarter vs prior year-93.0%+18.2%
KO leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

Evenly matched — CLB and RES each lead in 3 of 6 comparable metrics.

At 18.7x trailing earnings, CLB trades at a 59% valuation discount to RES's 45.9x P/E. On an enterprise value basis, RES's 6.5x EV/EBITDA is more attractive than KO's 25.9x.

MetricCLB logoCLBCore Laboratories…RES logoRESRPC, Inc.KO logoKOThe Coca-Cola Com…
Market CapShares × price$586M$1.5B$348.2B
Enterprise ValueMkt cap + debt − cash$769M$1.4B$383.5B
Trailing P/EPrice ÷ TTM EPS18.71x45.93x26.62x
Forward P/EPrice ÷ next-FY EPS est.21.24x35.52x24.75x
PEG RatioP/E ÷ EPS growth rate2.38x
EV / EBITDAEnterprise value multiple12.11x6.48x25.89x
Price / SalesMarket cap ÷ Revenue1.11x0.94x7.26x
Price / BookPrice ÷ Book value/share2.11x1.38x10.18x
Price / FCFMarket cap ÷ FCF25.93x28.85x65.76x
Evenly matched — CLB and RES each lead in 3 of 6 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 6 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $2 for RES. RES carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to KO's 1.33x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs RES's 4/9, reflecting strong financial health.

MetricCLB logoCLBCore Laboratories…RES logoRESRPC, Inc.KO logoKOThe Coca-Cola Com…
ROE (TTM)Return on equity+11.3%+1.9%+41.1%
ROA (TTM)Return on assets+5.2%+1.4%+13.1%
ROICReturn on invested capital+8.3%+4.8%+15.8%
ROCEReturn on capital employed+9.9%+4.6%+17.3%
Piotroski ScoreFundamental quality 0–9647
Debt / EquityFinancial leverage0.74x0.09x1.33x
Net DebtTotal debt minus cash$183M-$115M$35.2B
Cash & Equiv.Liquid assets$23M$210M$10.3B
Total DebtShort + long-term debt$206M$95M$45.5B
Interest CoverageEBIT ÷ Interest expense5.18x9.14x10.70x
KO leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

KO leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in KO five years ago would be worth $16,313 today (with dividends reinvested), compared to $2,851 for CLB. Over the past 12 months, RES leads with a +39.3% total return vs CLB's +5.3%. The 3-year compound annual growth rate (CAGR) favors KO at 12.6% vs CLB's -17.0% — a key indicator of consistent wealth creation.

MetricCLB logoCLBCore Laboratories…RES logoRESRPC, Inc.KO logoKOThe Coca-Cola Com…
YTD ReturnYear-to-date-24.8%+26.0%+18.6%
1-Year ReturnPast 12 months+5.3%+39.3%+17.7%
3-Year ReturnCumulative with dividends-42.8%-5.6%+42.6%
5-Year ReturnCumulative with dividends-71.5%+23.4%+63.1%
10-Year ReturnCumulative with dividends-83.0%-45.9%+118.2%
CAGR (3Y)Annualised 3-year return-17.0%-1.9%+12.6%
KO leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

KO leads this category, winning 2 of 2 comparable metrics.

KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than CLB's 0.96 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 96.3% from its 52-week high vs CLB's 62.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCLB logoCLBCore Laboratories…RES logoRESRPC, Inc.KO logoKOThe Coca-Cola Com…
Beta (5Y)Sensitivity to S&P 5000.96x0.35x-0.20x
52-Week HighHighest price in past year$20.36$8.16$84.04
52-Week LowLowest price in past year$9.72$4.18$65.35
% of 52W HighCurrent price vs 52-week peak+62.5%+84.4%+96.3%
RSI (14)Momentum oscillator 0–10041.252.960.8
Avg Volume (50D)Average daily shares traded445K1.8M12.7M
KO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

KO leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: CLB as "Hold", RES as "Hold", KO as "Buy". Consensus price targets imply 96.5% upside for CLB (target: $25) vs 6.5% for KO (target: $86). For income investors, KO offers the higher dividend yield at 2.52% vs CLB's 0.32%.

MetricCLB logoCLBCore Laboratories…RES logoRESRPC, Inc.KO logoKOThe Coca-Cola Com…
Analyst RatingConsensus buy/hold/sellHoldHoldBuy
Price TargetConsensus 12-month target$25.00$7.50$86.13
# AnalystsCovering analysts373648
Dividend YieldAnnual dividend ÷ price+0.3%+2.3%+2.5%
Dividend StreakConsecutive years of raises0056
Dividend / ShareAnnual DPS$0.04$0.16$2.04
Buyback YieldShare repurchases ÷ mkt cap+2.1%+0.2%+0.2%
KO leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

KO leads in 5 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.

Best OverallThe Coca-Cola Company (KO)Leads 5 of 6 categories
Loading custom metrics...

CLB vs RES vs KO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CLB or RES or KO a better buy right now?

For growth investors, RPC, Inc.

(RES) is the stronger pick with 15. 0% revenue growth year-over-year, versus 0. 5% for Core Laboratories N. V. (CLB). Core Laboratories N. V. (CLB) offers the better valuation at 18. 7x trailing P/E (21. 2x forward), making it the more compelling value choice. Analysts rate The Coca-Cola Company (KO) a "Buy" — based on 48 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CLB or RES or KO?

On trailing P/E, Core Laboratories N.

V. (CLB) is the cheapest at 18. 7x versus RPC, Inc. at 45. 9x. On forward P/E, Core Laboratories N. V. is actually cheaper at 21. 2x.

03

Which is the better long-term investment — CLB or RES or KO?

Over the past 5 years, The Coca-Cola Company (KO) delivered a total return of +63.

1%, compared to -71. 5% for Core Laboratories N. V. (CLB). Over 10 years, the gap is even starker: KO returned +118. 2% versus CLB's -83. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CLB or RES or KO?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

20β versus Core Laboratories N. V. 's 0. 96β — meaning CLB is approximately -579% more volatile than KO relative to the S&P 500. On balance sheet safety, RPC, Inc. (RES) carries a lower debt/equity ratio of 9% versus 133% for The Coca-Cola Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — CLB or RES or KO?

By revenue growth (latest reported year), RPC, Inc.

(RES) is pulling ahead at 15. 0% versus 0. 5% for Core Laboratories N. V. (CLB). On earnings-per-share growth, the picture is similar: The Coca-Cola Company grew EPS 23. 6% year-over-year, compared to -65. 1% for RPC, Inc.. Over a 3-year CAGR, KO leads at 3. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CLB or RES or KO?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus 2. 0% for RPC, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 3. 5% for RES. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CLB or RES or KO more undervalued right now?

On forward earnings alone, Core Laboratories N.

V. (CLB) trades at 21. 2x forward P/E versus 35. 5x for RPC, Inc. — 14. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLB: 96. 5% to $25. 00.

08

Which pays a better dividend — CLB or RES or KO?

All stocks in this comparison pay dividends.

The Coca-Cola Company (KO) offers the highest yield at 2. 5%, versus 0. 3% for Core Laboratories N. V. (CLB).

09

Is CLB or RES or KO better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

20), 2. 5% yield, +118. 2% 10Y return). Both have compounded well over 10 years (KO: +118. 2%, CLB: -83. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CLB and RES and KO?

These companies operate in different sectors (CLB (Energy) and RES (Energy) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

RES, KO pay a dividend while CLB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.